维普中文期刊产品整合服务
247篇 您的检索式:作者名="Lutgens E"
    题名 作者 年代 出处 被引量
1CD40-CD40L interactions in atherosclerosis 显示文摘Lutgens E Daemen MJ 2002Trends Cardiovasc Med2002,12,:1
2Genetic loss of Gas 6 induces plaque stability in experimental atherosclerosis显示文摘Lutgens E Tjwa M de Frutos PG 2008J Pathol2008,216,1:1
3Fibroblast growth factor 2 endocytosis in endothelial cells proceed via synclecan-4-dependent activation of Racl and a Cdc42-dependent macropinocytic pathway显示文摘Tkachenko E Lutgens E Stan R V 2004J Cell Sci2004,117,:1
4Both arly and delayed anti -CD40L antibody treatment induces a stable plaque phenotype 显示文摘Lutgens E Cleutjens KB Heeneman S 2000Proc Natl Acad Sci U S A2000,97,13:1
5CD40 -CD40L interactions in atherosclerosis 显示文摘Lutgens E Daemen MJ 2002Trends Cardiovasc Med2002,12,1:1
6Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation显示文摘Lutgens E Lutgens SP Faber BC 2006Circulation2006,113,1:1
7Genetic loss ofGas6 induces plaque stability in experimental atherosclerosis显示文摘Lutgens E Tjwa M Garcia de frutos P 2008J Pathol2008,216,1:1
8Requirement for CD154 in the progression of atherosclerosis显示文摘Lutgens E Gorelik L Daemen MJ 1999Nat Med1999,5,:1
9Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype显示文摘Lutgens E Cleutjens KB Heeneman S 2000Proc Natl Acad Sci USA2000,97,:1
10Loss of matrix metallo- proteinase-9 or matrix metalloproteinase-12 protects Apolipopro- tein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth显示文摘Luttun A Lutgens E Manderveld A 2004Circulation2004,109,11:1
11Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques显示文摘Dhore CR Cleuqells JP Lutgens E 2001Arterioseler Thromb Vase Biol2001,21,12:1
12Deficient CD 40-TRAF6sig-naling in leukocytes prevents atherosclerosis by skewing the im-mune response toward an antiinflammatory profile显示文摘Lutgens E Lievens D Beckers L 2010J Exp Med2010,207,2:1
13Differential ex- pression of bone matrix regulatory proteins in human athero- sclerotic plaques 显示文摘Dhore C-R Cleutjens J-P Lutgens E etal 2001Arterioscler-Thromb-Vasc-Biol2001,21,12:1
14Both early and delayed anti-CD 40 L antibody treatment induces a stable plaquephenotype显示文摘Lutgens E Cleutjens K B Heeneman S 2000Proe Nat[ Acad Sei2000,9,13:1
15Leukocyte counts, myeloperoxi-dase, and pregnancy-associated plasma protein a as bio- markers for cardiovascular disease: towards a multi-biomarker approach 显示文摘Lobbes MB Kooi ME Lutgens E 2010Int J VaseMed2010,26,18:1
16Atherosclerosisin ApoE* 3-Leiden transgenicmice: from proliferative toatheromatous stage显示文摘Lutgens E Daemen M Kockx M 1999Circ1999,99,2:1
17Atherosclerotic plaque rapture : local or systemic process 显示文摘Lutgens E van Suylen R J Faber BC 2003? Arterioscler Thromb Vasc Biol2003,23,12:1
18Transforming growth factor- beta Mediates balance between inflammation and fibrosis during plaque progression 显示文摘Lutgens E Gijbels M Smook M 2002Arterioscler Thromb Vasc Biol2002,22,6:1
19Biphasicpattern of cell turnovercharacterizes the progressionfrom fatty streaks to ruptured humanatheroscleroticplaques显示文摘Lutgens E de Muinck ED Kitslaar PJ 1999Cardiov Res1999,41,2:1
20Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques 显示文摘Dhore CR Cleutjens JP Lutgens E 2001Arterioseler Thromb Vase Biol2001,21,12:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费